Nutrition & Lifestyle
    Retatrutide

    Retatrutide Meal Plan: What to Eat and When (2026 Guide)

    There is no official diet for retatrutide, because the drug is still in phase 3 trials. Here is the working nutrition playbook under strong appetite suppression: protein first, fluids between meals, micronutrient coverage, and a 7-day framework of food ideas.

    Published April 3, 2026Updated August 24, 202610 min read

    Retatrutide is an investigational medication in clinical trials. It is not FDA-approved, is not legally compoundable, and is not available through Trimi. Trimi does not offer it and has no plans to. This article is editorial safety coverage for people researching the drug-development pipeline.

    Quick answer

    Eat protein first at every meal, aim for roughly 1.2-1.6 g of protein per kg of body weight daily, split food into 4 to 6 small eating occasions instead of 3 large meals, and drink fluids between meals rather than with them. No retatrutide-specific nutrition studies exist, so this playbook is extrapolated from clinical nutrition guidance for the approved incretin class.

    How to Eat on Retatrutide: The Direct Answer

    A meal plan under potent appetite suppression solves a different problem than a normal diet. You are not fighting hunger; the drug removes most of it. The problem is the opposite one: eating so little that protein, fluids, vitamins, and minerals fall short while the scale drops. So the plan is built on four rules. Protein first on every plate. Small, scheduled eating occasions instead of waiting for hunger that may not arrive. Fluids between meals, not with them, so limited stomach capacity goes to food. And nutrient-dense choices, because every bite has to work harder when there are fewer of them.

    The scale of the suppression is what makes structure necessary. According to the 2023 NEJM phase 2 trial (Jastreboff et al.), retatrutide produced a mean weight reduction of up to 24.2% at 48 weeks at the highest dose, more than the 14.9% seen with semaglutide in STEP 1 at 68 weeks or the 20.9% seen with the top tirzepatide dose in SURMOUNT-1 at 72 weeks. And with a half-life of approximately 6 days, the appetite suppression does not take days off between injections. The drug is still moving through the phase 3 TRIUMPH program, so there is no approved label and no official nutrition guidance; everything here extrapolates from the approved incretin class.

    Protein First: The Non-Negotiable

    Weight lost rapidly is never all fat. Without deliberate countermeasures, a meaningful share comes from muscle, which costs strength, function, and resting metabolic rate, and makes regain easier later. The two countermeasures with the best support are adequate protein and resistance training two to three times per week. Clinical nutrition consensus for people losing weight puts the protein target at roughly 1.2-1.6 g per kg of body weight per day, and some clinicians go higher for maximum lean-mass preservation. For a 91 kg (200 lb) person, the standard range works out to about 109-146 g daily, which takes real planning when total intake is a fraction of what it used to be.

    The tactic that does most of the work is protein-first plating: eat the protein portion of the meal before anything else, so that when fullness arrives early, it is the rice or the salad that gets left behind, not the chicken. Our full guide to protein intake on retatrutide covers the targets and the evidence in depth, and our list of the best protein foods on GLP-1 medications ranks specific foods by protein delivered per bite.

    Hydration: The Second Priority

    Appetite suppressants quietly suppress drinking too. Roughly a fifth of normal fluid intake arrives through food, so eating far less means drinking more on purpose, and blunted thirst signals mean you cannot rely on feeling thirsty. The National Academies' dietary reference intakes put adequate total water at about 3.7 liters per day for men and 2.7 liters for women from all sources combined. The practical method: keep a bottle within reach, sip steadily between meals, and stop drinking about 30 minutes before eating so fluid does not fill the limited stomach capacity that food needs.

    Hydration is also a safety issue, not just a comfort issue. In the incretin class, the reported cases of acute kidney injury cluster around severe dehydration from vomiting or diarrhea. If fluids will not stay down for more than a day, that is a clinician call, not a hydration strategy problem.

    Micronutrients: The Quiet Risk of Eating Very Little

    When food intake drops steeply, vitamins and minerals drop with it. The nutrients that tend to fall short first on very low intakes are iron, calcium, vitamin B12, vitamin D, and fiber. The food-first fixes are unglamorous: eggs and dairy for B12 and calcium, leafy greens and legumes for iron and folate, vegetables and berries for fiber in small volumes. A standard multivitamin is a reasonable backstop during rapid weight loss, but it is worth clearing with a clinician first, and it is a supplement to nutrient-dense eating, not a substitute for it. Constipation deserves special mention: less food plus less fluid plus slowed gut motility makes it one of the most common complaints in this drug class, and fluid plus fiber plus walking is the first-line answer.

    Meal Timing and Portion Structure

    Waiting for hunger is the most common structural mistake, because on a drug this strong, hunger may simply not show up. The pattern that works is scheduled eating: 4 to 6 small occasions at roughly consistent times, each anchored by protein, each ended at the first clear signal of fullness. Small and frequent beats large and rare for two reasons: a slowed stomach tolerates small volumes far better, and more occasions mean more chances to hit the protein target.

    For the same reason, stacking time-restricted eating on top of pharmacological appetite suppression usually backfires: two independent brakes on intake operate at once, and protein is what gets crushed. If you are considering a compressed eating window anyway, read our piece on retatrutide and intermittent fasting first, and the broader GLP-1 fasting guide for how clinicians think about fasting in this class generally.

    A 7-Day Framework of Food Ideas (Not a Prescription)

    Day 1: Scrambled eggs with spinach; Greek yogurt with berries; chicken and vegetable soup; baked salmon with roasted zucchini.

    Day 2: Cottage cheese with sliced peach; hard-boiled egg; tuna salad in lettuce cups; shredded chicken with mashed sweet potato.

    Day 3: Protein smoothie with half a banana and spinach; string cheese; lentil soup; turkey chili with beans.

    Day 4: Greek yogurt with ground flaxseed; drinkable yogurt; leftover turkey chili; baked cod with steamed green beans.

    Day 5: Veggie omelet with feta; small handful of almonds; egg salad on whole grain toast; chicken thigh with roasted carrots and quinoa.

    Day 6: Protein oatmeal (oats cooked with milk, protein powder stirred in); edamame; broth-based miso soup with tofu; shrimp stir-fry with mixed vegetables.

    Day 7: Cottage cheese with cucumber; protein shake; rotisserie chicken and avocado plate; lean beef and vegetable stew.

    Portions flex with appetite: on low-appetite days, lean on the liquid options and eat the protein portion only. Every day targets a protein anchor at each occasion. Swap freely for foods you tolerate; the structure matters more than the menu.

    Safety Flags: When Eating Less Becomes a Problem

    Two patterns should prompt a check-in with a clinician rather than a diet adjustment. The first is too-rapid loss: weight falling well beyond what was expected, especially with weakness, dizziness, or hair shedding, which raises the risk of muscle loss, gallstones, and nutrient deficiencies. Trial figures like the ones above are averages, and individual results vary widely in both directions. The second is intake failure: days where meaningful food or fluid will not stay down at all.

    Both sit inside the class-wide safety picture. Per FDA prescribing information for the approved incretin medicines, the most common adverse reactions include nausea, vomiting, diarrhea, and constipation, and clinicians monitor for pancreatitis, gallbladder disease, and kidney injury when severe GI losses cause dehydration. The class also carries a boxed-warning context around thyroid C-cell tumors observed in rodent studies. None of that is a reason to panic over a rough day; it is a reason to treat persistent inability to eat or drink as a medical question. Our side effects management hub covers the practical playbook for the whole class.

    One last point worth being explicit about: nothing in this framework is retatrutide-specific. The same protein-first, small-portion, fluids-between-meals structure applies to any potent incretin therapy, including the semaglutide and tirzepatide medicines that clinicians can actually prescribe today while retatrutide remains in trials.

    Available today by prescription

    Looking for a medication you can actually get now?

    Retatrutide is still in clinical trials and is not available anywhere outside of them. If you want treatment that you can actually start today, licensed clinicians can prescribe compounded semaglutide ($99/month on the annual plan) or compounded tirzepatide ($125/month on the annual plan) when appropriate, with provider review, medication, and shipping included.

    Start your online visit

    Frequently Asked Questions

    How many calories should I eat on retatrutide?

    There is no retatrutide-specific calorie target, because no nutrition trials have been published for the drug. Most people on potent incretin therapy naturally settle at a much lower intake than before, and the practical goal is not a calorie number but coverage: roughly 1.2-1.6 g of protein per kg of body weight daily, fluids between meals, and nutrient-dense foods. If your intake stays very low for weeks at a time, that is worth a conversation with a clinician or registered dietitian rather than something to push through alone.

    What foods work best when appetite is minimal?

    Foods that deliver the most protein and micronutrients per bite: eggs, Greek yogurt, cottage cheese, fish, poultry, tofu, lentils, and broth-based soups. Liquid options such as protein shakes, drinkable yogurt, and smoothies are often tolerable on days when solid food is unappealing. Small portions of soft, plain foods usually sit better than large, rich meals.

    What foods tend to make GLP-1 class side effects worse?

    The common offenders are high-fat fried foods, very large meals, heavily processed sweets, carbonated drinks, and alcohol. Incretin drugs slow stomach emptying, so a big greasy meal sits longer and is more likely to trigger nausea or reflux. Eating slowly, stopping at the first signal of fullness, and separating fluids from solids all reduce the load on a slowed stomach.

    Do I have to follow the 7-day plan exactly?

    No. It is a framework of ideas, not a prescription. Swap any protein for one you tolerate: vegetarians can use tofu, tempeh, legumes, eggs, and dairy; gluten-free eaters can change the grains. The structure is what matters: a protein anchor at every eating occasion, small portions, and 4 to 6 occasions per day rather than 3 large meals.

    How much water should I drink on retatrutide?

    The National Academies' dietary reference intakes put adequate total water at roughly 3.7 liters per day for men and 2.7 liters for women, from all beverages and food combined. On an appetite suppressant you lose the fluid you would normally get from food, and thirst signals are often blunted, so schedule sips between meals rather than waiting to feel thirsty. Vomiting or diarrhea raises the stakes: dehydration is the pathway to the kidney injury cases reported in this drug class.

    Is rapid weight loss on retatrutide dangerous?

    Very fast loss raises three specific risks: muscle loss, gallstones, and nutrient deficiencies. Weight lost quickly is never all fat, and without deliberate protein intake plus resistance training a meaningful share comes from lean tissue. Rapid loss is also a known trigger for gallbladder disease. If weight is falling much faster than your clinician expected, or you feel weak, dizzy, or unable to keep fluids down, that is a reason to check in, not to celebrate.

    This article is general information, not medical or nutritional advice. Individual needs vary with health conditions, medications, and kidney function; consult a licensed clinician or registered dietitian before making significant dietary changes. Compounded medications are prepared per individual prescription by a state-licensed 503A pharmacy and are not themselves FDA-approved as drugs.

    Related Reading

    Sources & References

    1. Jastreboff AM et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial. NEJM 2023. pubmed.ncbi.nlm.nih.gov/37366315
    2. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM 2021. pubmed.ncbi.nlm.nih.gov/33567185
    3. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM 2022. pubmed.ncbi.nlm.nih.gov/35658024
    4. Institute of Medicine. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. National Academies Press, 2005. nap.nationalacademies.org/catalog/10925
    5. U.S. Food and Drug Administration. Human Drug Compounding. fda.gov/drugs/human-drug-compounding
    6. ClinicalTrials.gov, U.S. National Library of Medicine. clinicaltrials.gov

    What does the current clinical evidence support for GLP-1-based weight management?

    GLP-1 receptor agonists (semaglutide, tirzepatide) have Phase 3 RCT evidence for chronic weight management in adults with BMI ≥30 or BMI ≥27 with a weight-related comorbidity. Trimi offers compounded semaglutide at $99/month and compounded tirzepatide at $125/month on the annual plan, prepared per individual prescription by 503A community sterile compounding pharmacies and reviewed by a US-licensed clinician through Arora Health's 50-state provider network. Compounded preparations are not themselves FDA-approved as drugs. Eligibility is determined by a licensed clinician.

    Phase 3 RCT evidence base: STEP 1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), FLOW (NEJM 2024)
    Trimi pricing: $99/month semaglutide / $125/month tirzepatide on annual plan
    Clinical review: Dr. Sean Arora, MD via Arora Health 50-state network

    Key Takeaways

    • Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by 503A community sterile compounding pharmacies (VialsRx, Texas State Board pharmacy license #35264, and GreenwichRx). The active ingredients (semaglutide, tirzepatide) are FDA-approved in the corresponding brand finished products (Wegovy / Ozempic and Zepbound / Mounjaro respectively). Compounded preparations are not themselves FDA-approved as drugs.
    • Eligibility for GLP-1 treatment is determined by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Most are mild-to-moderate and concentrated during dose escalation. Severe gastrointestinal symptoms causing dehydration can increase acute kidney injury risk and should be reported to the prescribing clinician.
    • Trimi's clinical review is coordinated by Dr. Sean Arora, MD through Arora Health's 50-state provider network. Trimi pricing: $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan; flat across all prescribed doses within whichever plan, with no enrollment / consultation / shipping fees.
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: January 8, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Just recieved my order today. I placed order Monday afternoon and arrived this afternoon. Everything packaged great, clear instructions to follow. The customer service was excellent. I have tried other companies, but this is the most affordable by far. I am almost at my goal weight.

    Outcome: Next-day arrival; most affordable tried; near goal weight

    - Raquel R.Facebook
    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    - Robyn C.Facebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    2. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    3. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Why weight loss stalls on retatrutide: metabolic adaptation, dose ceilings, calorie creep, unverified gray-market potency, and when a stall signals risk.

    Retatrutide vs phentermine: mechanisms, trial evidence, side effects, and approval status compared. One is prescribable today, one is still in trials.

    How much protein you need on retatrutide: targets per kg, lean-mass preservation during rapid weight loss, and strategies when appetite is minimal.

    Combining retatrutide with intermittent fasting: under-fueling risks, hydration and protein floors, who should avoid it, and safer ways to structure it.

    Start your GLP-1 journey, from $99/mo

    Get Started